AIG
GALT icon

American International Group’s Galectin Therapeutics GALT Stock Holding History

American International Group’s Portfolio GALT Stock Details GALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-21,677
Closed -$47 – 3182
2021
Q1 		$47 Buy
21,677
+58
+0.3% +$130 ﹤0.01% 2997
2020
Q4 		$48 Sell
21,619
-622
-3% -$1.63K ﹤0.01% 2971
2020
Q3 		$59K Sell
22,241
-505
-2% -$1.41K ﹤0.01% 2820
2020
Q2 		$70K Sell
22,746
-966
-4% -$2.43K ﹤0.01% 2739
2020
Q1 		$46K Sell
23,712
-1,370
-5% -$3.33K ﹤0.01% 2710
2019
Q4 		$72K Sell
25,082
-212
-0.8% -$737 ﹤0.01% 2771
2019
Q3 		$93K Buy
25,294
+4,788
+23% +$17.3K ﹤0.01% 2652
2019
Q2 		$85K Buy
+20,506
New +$88.8K ﹤0.01% 2761
2016
Q2 		– Sell
-349,425
Closed -$500K – 3583
2016
Q1 		$500K Buy
349,425
+79,500
+29% +$107K ﹤0.01% 2013
2015
Q4 		$443K Buy
269,925
+32,000
+13% +$73.3K ﹤0.01% 2134
2015
Q3 		$557K Buy
237,925
+44,300
+23% +$104K ﹤0.01% 1922
2015
Q2 		$529K Buy
193,625
+19,523
+11% +$58.9K ﹤0.01% 2128
2015
Q1 		$583K Buy
174,102
+161,775
+1,312% +$578K ﹤0.01% 2031
2014
Q4 		$42.8K Buy
12,327
+552
+5% +$2.44K ﹤0.01% 4040
2014
Q3 		$59.2K Sell
11,775
-9
-0.1% -$70 ﹤0.01% 3899
2014
Q2 		$163K Buy
+11,784
New +$147K ﹤0.01% 3172

Other funds holding GALT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
GWM
Geneos Wealth Management Englewood, Colorado $4.31B AUM 18.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCB
Cutter & Co Brokerage Ballwin, Missouri $423M AUM 15.02% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American International Group's GALT Position: Q2 2021 in Review

American International Group sold out of Galectin Therapeutics (GALT) in Q2 2021, closing a stake of 21,677 shares — an estimated $47 sold.

American International Group first reported a position in GALT in Q2 2014 and held it in 16 quarters. The position peaked at $583K in Q1 2015. 75 funds tracked by Wall St. Rank hold GALT as of Q2 2021.

  • American International Group reported no remaining Galectin Therapeutics position as of Q2 2021 after selling out during the quarter.
  • American International Group sold 21,677 Galectin Therapeutics shares in Q2 2021, an estimated $47.
  • American International Group first reported a position in Galectin Therapeutics in Q2 2014 and held it in 16 quarters.
  • American International Group's Galectin Therapeutics position peaked at $583K in Q1 2015.
  • 75 funds tracked by Wall St. Rank held Galectin Therapeutics as of Q2 2021.

Based on American International Group's 13F filing for Q2 2021, filed 13 Aug 2021.